Literature DB >> 1092410

Editorial: Current status of antilymphocyte globulin.

.   

Abstract

Mesh:

Substances:

Year:  1975        PMID: 1092410      PMCID: PMC1672911          DOI: 10.1136/bmj.1.5959.644

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  9 in total

Review 1.  The selective action of antilymphocyte serum on recirculating lymphocytes: a review of the evidence and alternatives.

Authors:  E M Lance
Journal:  Clin Exp Immunol       Date:  1970-06       Impact factor: 4.330

2.  Intensive immunosuppression in the treatment of multiple sclerosis.

Authors:  J Ring; J Seifert; G Lob; K Coulin; H Angstwurm; E Frick; B Brass; J Mertin; H Backmund; W Brendel
Journal:  Lancet       Date:  1974-11-09       Impact factor: 79.321

3.  Risk of cancer in renal-transplant recipients.

Authors:  R Hoover; J F Fraumeni
Journal:  Lancet       Date:  1973-07-14       Impact factor: 79.321

4.  Treatment of Moloney lymphoma with lethal doses of dimethyl-myleran combined with injections of haemopoietic cells.

Authors:  G L Floersheim
Journal:  Lancet       Date:  1969-02-01       Impact factor: 79.321

Review 5.  Anti-lymphocytic antibody--a review.

Authors:  K James
Journal:  Clin Exp Immunol       Date:  1967-11       Impact factor: 4.330

6.  Antilymphocyte antisera in immunologically mediated renal disease.

Authors:  B Pirofsky; E J Bardana; C Bayracki; G A Porter
Journal:  JAMA       Date:  1969-11-10       Impact factor: 56.272

7.  An analysis of the multiplicity of the effects of antilymphocyte serum. A comparison with the action of other immunosuppressive agents in the cell-mediated immune response and non-specific inflammation.

Authors:  J L Turk; D A Willoughby
Journal:  Antibiot Chemother       Date:  1969

8.  [Antilymphocyte serum therapy in human autoimmune diseases].

Authors:  F Trepel; R Pichlmayr; J Kimura; W Brendel; H Begemann
Journal:  Klin Wochenschr       Date:  1968-08-15

Review 9.  Anti-lymphocytic antibody and autoimmune disease: a review.

Authors:  A M Denman
Journal:  Clin Exp Immunol       Date:  1969-09       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.